SCHEMBL29535649

SCHEMBL29535649

[107Cd]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL29350294 1.00
SCHEMBL97724 1.00
SCHEMBL2997438 1.00
Lithium Ion SCHEMBL278068 0.71
Lithium Ion SCHEMBL3894889 0.71 CYP3A4 (0.33)
Lithium Ion SCHEMBL2020200 0.71
Bromide SCHEMBL34701 0.71
Lithium Ion SCHEMBL28778 0.71
Fluoride Ion SCHEMBL2951767 0.71 CA4 (0.50)
Lithium Ion SCHEMBL20533709 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260069726-A1 ZWITTERIONIC COMPOUNDS AND USES THEREOF UNIV SASKATCHEWAN (CA) 2026-03-12 US claimed
US-12479792-B2 Compositions of chelating molecules THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-11-25 US claimed
EP-3503930-B1 CHELATING PLATFORM FOR DELIVERY OF RADIONUCLIDES FRED HUTCHINSON CANCER CENTER (US) 2024-12-11 EP claimed
WO-2023235985-A1 ZWITTERIONIC COMPOUNDS AND USES THEREOF UNIVERSITY OF SASKATCHEWAN (CA) 2023-12-14 WO claimed
US-20220160904-A1 CHELATING PLATFORM FOR DELIVERY OF RADIONUCLIDES FRED HUTCHINSON CANCER RESEARCH CENTER (US) 2022-05-26 US claimed
US-20260083865-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF 3B PHARMACEUTICALS GMBH (DE) 2026-03-26 US disclosed
US-20260069726-A1 ZWITTERIONIC COMPOUNDS AND USES THEREOF UNIV SASKATCHEWAN (CA) 2026-03-12 US disclosed
US-20260056336-A1 CZT DETECTORS AND METHODS OF USE THEREOF GEORGIA TECH RES INST (US) 2026-02-26 US disclosed
US-12479792-B2 Compositions of chelating molecules THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-11-25 US disclosed
US-20250339569-A1 CARBONIC ANHYDRASE IX LIGANDS 3B PHARMACEUTICALS GMBH (DE) 2025-11-06 US disclosed
EP-4619411-A1 DUAL RECEPTOR TARGETING RADIOLIGANDS AND USES THEREOF Full-Life Technologies HK Limited (HK) 2025-09-24 EP disclosed
EP-4583917-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF 3B Pharmaceuticals GmbH (DE) 2025-07-16 EP disclosed
US-20230071385-A1 LIGHT EMITTING DEVICE, DISPLAY DEVICE, PHOTOELECTRIC CONVERSION DEVICE, ELECTRONIC DEVICE, ILLUMINATION DEVICE, AND MOBILE DEVICE CANON KK (JP) 2023-03-09 US disclosed
EP-4139218-A1 TRIANGULAR PACKAGES HAVING AUTOBOTTOMS AND BLANKS THEREFOR WestRock Shared Services, LLC (US) 2023-03-01 EP disclosed
WO-2023002045-A1 FIBROBLAST ACTIVATION PROTEIN INHIBITORS AND USE THEREOF 3B PHARMACEUTICALS GMBH (DE) 2023-01-26 WO disclosed
US-11527591-B2 Light emitting device for display device miniaturizing pixels and suppressing degradation in image quality CANON KABUSHIKI KAISHA (JP) 2022-12-13 US disclosed
US-20220160904-A1 CHELATING PLATFORM FOR DELIVERY OF RADIONUCLIDES FRED HUTCHINSON CANCER RESEARCH CENTER (US) 2022-05-26 US disclosed
WO-2022099420-A1 CYCLOTRON TARGET AND LANTHANUM THERANOSTIC PAIR FOR NUCLEAR MEDICINE THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) 2022-05-19 WO disclosed
CN-110650689-B Device and method for diagnosing sinusitis 恩特范特格诊断公司 2022-05-17 CN disclosed
US-20220106623-A1 SPATIAL MAPPING OF CELLS AND CELL TYPES IN COMPLEX TISSUES FRED HUTCHINSON CANCER RESEARCH CENTER (US) 2022-04-07 US disclosed